Here is a well-sourced answer:
Folic Acid Before Conception in Scoliosis Post-Surgery: Is 5 mg Required?
Short answer: Scoliosis itself (and its surgical correction) is NOT a standard indication for high-dose folic acid 5 mg preconceptionally. The 5 mg dose is reserved for specific high-risk conditions. Here is the full breakdown:
Standard Preconception Folic Acid Dosing
| Risk Category | Dose | Timing |
|---|
| Low risk (general population) | 0.4–0.8 mg/day | At least 1 month before conception through the 1st trimester |
| High risk (NTD recurrence, anticonvulsants, etc.) | 4–5 mg/day | At least 3 months before conception |
When is High-Dose (4–5 mg) Folic Acid Indicated?
The 5 mg (or 4 mg) dose is indicated for women at genuinely elevated risk of neural tube defects (NTDs), specifically:
- Previous pregnancy affected by an NTD — 4 mg/day reduces recurrence risk by ~70% (Creasy & Resnik's Maternal-Fetal Medicine)
- Women taking antiepileptic drugs (AEDs) — especially valproate, carbamazepine, phenytoin; these interfere with folate absorption (Bradley & Daroff's Neurology in Clinical Practice)
- Diabetes mellitus (pre-gestational)
- BMI ≥ 35
- Family history of NTDs (first-degree relative)
- Malabsorption syndromes (celiac disease, IBD, bariatric surgery)
- MTHFR gene mutation (in some guidelines)
Where Scoliosis Post-Surgery Fits
Idiopathic scoliosis — the most common type — is not a neural tube defect and does not confer an elevated NTD recurrence risk in offspring. Spinal instrumentation/fusion for scoliosis does not change the folic acid requirement.
However, there are two important nuances:
-
Congenital scoliosis (caused by vertebral segmentation defects) has an association with neural tube defects and may be considered by some clinicians as a reason to use higher-dose supplementation — though formal guidelines do not uniformly mandate 5 mg for this indication.
-
Neuromuscular scoliosis (e.g., spina bifida-related) — here the patient has an NTD themselves; this does warrant 4–5 mg preconceptionally, not because of the scoliosis per se, but because having an NTD-related condition indicates higher offspring NTD risk.
Guideline Recommendations (2022–2023)
- SOGC Guideline No. 427 (2022) — Wilson & O'Connor: Recommends 0.4–1 mg/day for low-risk women; 4–5 mg/day for high-risk (prior NTD, AEDs, DM, BMI ≥35) starting at least 3 months before conception [PMID: 35691683]
- USPSTF (2023) — Recommends 0.4–0.8 mg/day for all women planning pregnancy; higher doses only under physician supervision [PMID: 37526714]
- Creasy & Resnik: "Periconceptional folic acid supplementation (4 mg/d) reduces risk of recurrence [of NTDs] by 70%"
Bottom Line
| Scenario | Folic Acid Recommendation |
|---|
| Idiopathic scoliosis s/p spinal fusion | 0.4–0.8 mg/day (standard dose) |
| Congenital scoliosis (vertebral malformations) | Consider 5 mg/day (discuss with specialist) |
| Neuromuscular scoliosis (e.g., spina bifida) | 4–5 mg/day for 3 months preconception |
| On AEDs for neuromuscular disease + scoliosis | 4–5 mg/day (AED indication) |
The "5 mg for 3 months preconception" recommendation applies to high-NTD-risk states — not to scoliosis surgery per se. Unless the patient has a co-existing high-risk condition (NTD history, AED use, prior NTD-affected pregnancy, DM, obesity), the standard 0.4–0.8 mg daily dose is appropriate.
Sources: Creasy & Resnik's Maternal-Fetal Medicine; Bradley & Daroff's Neurology in Clinical Practice; SOGC Guideline No. 427 [PMID 35691683]; USPSTF Systematic Review 2023 [PMID 37526714]